| Necroptosis: who knew there were so many interesting ways to die? SM Fayaz, VS Suvanish Kumar, GK Rajanikant CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 73 | 2014 |
| CypD: the key to the death door S M Fayaz, Y V Raj, R G Krishnamurthy CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2015 | 34 | 2015 |
| ZIF-8 nano confined protein-titanocene complex core-shell MOFs for efficient therapy of Neuroblastoma: Optimization, molecular dynamics and toxicity studies S Kulkarni, A Pandey, AN Nikam, SH Nannuri, SD George, SMA Fayaz, ... International Journal of Biological Macromolecules 178, 444-463, 2021 | 19 | 2021 |
| Evolutionary patterning of hemagglutinin gene sequence of 2009 H1N1 pandemic R Banerjee, A Roy, F Ahmad, S Das, S Basak Journal of Biomolecular Structure and Dynamics 29 (4), 733-742, 2012 | 18 | 2012 |
| Amikacin inhibits miR-497 maturation and exerts post-ischemic neuroprotection S Sinoy, SM Fayaz, KD Charles, VK Suvanish, JP Kapfhammer, ... Molecular neurobiology 54, 3683-3694, 2017 | 15 | 2017 |
| Ensemble pharmacophore meets ensemble docking: a novel screening strategy for the identification of RIPK1 inhibitors SM Fayaz, GK Rajanikant Journal of computer-aided molecular design 28, 779-794, 2014 | 15 | 2014 |
| A novel five-node feed-forward loop unravels miRNA-gene-TF regulatory relationships in ischemic stroke SS Nampoothiri, SM Fayaz, GK Rajanikant Molecular Neurobiology 55, 8251-8262, 2018 | 14 | 2018 |
| Novel RIPK3 inhibitors discovered through a structure-based approach exert post-ischemic neuroprotection SM Fayaz, VS Suvanish Kumar, CK Davis, GK Rajanikant Molecular diversity 20, 719-728, 2016 | 13 | 2016 |
| In silico prediction of novel inhibitors of the DNA binding activity of FoxG1 S Bhuvanachandran Nair, S Mahammad Abdul Fayaz, ... Medicinal Chemistry 8 (6), 1155-1162, 2012 | 13 | 2012 |
| Identification of gene network motifs for cancer disease diagnosis R Gupta, SM Fayaz, S Singh 2016 IEEE Distributed Computing, VLSI, Electrical Circuits and Robotics …, 2016 | 12 | 2016 |
| Finding needles in a haystack: application of network analysis and target enrichment studies for the identification of potential anti-diabetic phytochemicals SM Fayaz, VS Suvanish Kumar, KG Rajanikant PloS one 9 (11), e112911, 2014 | 12 | 2014 |
| A novel multi-target drug screening strategy directed against key proteins of DAPk family S B Nair, S M Fayaz, G K Rajanikant Combinatorial Chemistry & High Throughput Screening 16 (6), 449-457, 2013 | 11 | 2013 |
| Factors affecting the morphology of some organic and inorganic nanostructures for drug delivery: characterization, modifications, and toxicological perspectives R Raychaudhuri, A Pandey, A Hegde, SM Abdul Fayaz, DK Chellappan, ... Expert opinion on drug delivery 17 (12), 1737-1765, 2020 | 8 | 2020 |
| Ensembling and filtering: an effective and rapid in silico multitarget drug-design strategy to identify RIPK1 and RIPK3 inhibitors SM Fayaz, GK Rajanikant Journal of molecular modeling 21, 1-13, 2015 | 6 | 2015 |
| Repressor Element-1 Binding Transcription Factor (REST) as a Possible Epigenetic Regulator of Neurodegeneration and MicroRNA-Based Therapeutic Strategies A Nassar, S Satarker, PC Gurram, D Upadhya, SM Fayaz, M Nampoothiri Molecular Neurobiology 60 (10), 5557-5577, 2023 | 5 | 2023 |
| Phytotherapeutics against Alzheimer’s disease: mechanism, molecular targets and challenges for drug development S Gayathri, CH Raghu, SM Fayaz CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2022 | 5 | 2022 |
| Modelling the molecular mechanism of protein–protein interactions and their inhibition: CypD–p53 case study SM Fayaz, GK Rajanikant Molecular diversity 19, 931-943, 2015 | 5 | 2015 |
| Commentary: Research Highlights ATF4: The Perpetrator in Axonal-Mediated Neurodegeneration in Alzheimer's Disease SM Fayaz, GK Rajanikant CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 5 | 2014 |
| Carnosine-induced neuroprotection SM Fayaz, A Majid, GK Rajanikant | 3 | 2015 |
| Commentary-1 (research highlights: USP30 regulates the mitophagy-mediated neuroprotection in Parkinson’s disease) R G Krishnmurthy, F M Shradgan CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 2 | 2014 |
